Researchers conducted a cohort study to assess the risks for azoospermia and prostate cancer among men with female relatives who have primary ovarian insufficiency.

Researchers evaluated opioid prescribing trends by provider type for emergency department visits at noninstitutional and short-stay hospitals from 2019 to 2021.

The Food and Drug Administration (FDA) has approved the combination of nivolumab (Opdivo ®) plus ipilimumab (Yervoy ® ), both from Bristol Myers Squibb Company, as an option for first-line therapy for ...

Investigators studied cancer incidence, survival outcomes, and graft function among a multicenter cohort of kidney transplant recipients.

Patients with MSI-H mCRC had a higher probability of survival with first-line ICI therapy than with chemotherapy, but second-line or later ICIs did not confer the same benefit.

HealthDay News — Exercise and rehabilitation services for patients with breast cancer through a clinical workflow algorithm called CORE (Comprehensive Oncology Rehabilitation and Exercise) is feasible ...

Overall survival after HCT for high-risk features in patients with SDS was superior to OS for HCT for MDS/AML, particularly ...

Pediatric patients with angiosarcoma were found to have a higher survival rate than their adult counterparts and may benefit from more aggressive treatments.

A pooled analysis of individual data from 5 COG studies demonstrated that race/ethnicity has no significant effect on survival for children and AYAs with cancer receiving treatment on clinical trial.

A novel assessment tool builds a bridge between nursing and finance that translates to improved nurse-to-patient ratios and ...

Results of a randomized, placebo-controlled study demonstrated avatrombopag achieved the primary endpoint of platelet response in heavily pretreated pediatric patients with persistent or chronic ITP.

Combination treatment with a PARP inhibitor and an anti-angiogenic agent did not improve PFS when compared to chemotherapy or ...